Drug Patent Watch

FEBRUARY 11, 2025

The Dark Side of Innovation: How Companies Use Drug Patents to Block Competitors As we celebrate the breakthroughs in medical research and the development of life-saving treatments, it's essential to acknowledge the complex landscape of pharmaceutical innovation. One of the most effective tools in their arsenal is the use of drug patents.

Drugs 96

Drugs Treatment Marketing Production 96

BioPharma Drive: Drug Pricing

MARCH 25, 2025

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed geographic atrophy medicines.

Treatment 204

Treatment Marketing Drugs 204

Drug Target Review

NOVEMBER 25, 2024

As the CEO of iOnctura, an innovative oncology biopharmaceutical company she co-founded in 2017, Catherine has played a key role in advancing the development of highly targeted small molecules aimed at revolutionising cancer treatment. This is exciting because often resistance builds up to these other treatments.

Treatment 52

Treatment Small Molecule Clinical Trials Trials 52

Nvidia Developer: Drug Discovery

OCTOBER 30, 2024

The integration of AI in drug discovery is revolutionizing the way researchers approach the development of new treatments for various diseases. The integration of AI in drug discovery is revolutionizing the way researchers approach the development of new treatments for various diseases. Traditional.

Drugs 87

Drugs Treatment Disease Research 87

Drugs.com

OCTOBER 27, 2023

26, 2023 -- Dozens of fly-by-night businesses are marketing unproven and potentially dangerous stem cell treatments to people experiencing long COVID, a new study warns. THURSDAY, Oct. Researchers have identified 38 businesses engaged in.

Treatment 203

Treatment Marketing Research 203

Drug Patent Watch

FEBRUARY 13, 2025

The Unsung Heroes of Generic Drug Development: The Power of Partnerships As we navigate the complex landscape of pharmaceuticals, it's easy to overlook the crucial role that partnerships play in bringing affordable, life-saving medications to market. When it comes to developing generic drugs, partnerships can take many forms.

Drug Development 83

Drug Development Drugs Pharmaceutical Companies Treatment 83

Drug Target Review

DECEMBER 20, 2024

These innovations have started to shift industry perceptions, positioning AI as a transformative tool that could alter how drugs are developed, tested, and brought to market. By increasing the chances that more participants will receive the treatment being tested, recruitment becomes more efficient, speeding up the overall trial process.

Clinical Trials 128

Clinical Trials Trials Pharmaceuticals Drug Development 128

BioPharma Drive: Drug Pricing

APRIL 9, 2025

market, bladder cancer treatment Adstiladrin earned about $77 million. In its first full year on the U.S. Elsewhere, Lilly backed a cancer drug startup and Bristol Myers won a new Opdivo approval.

Therapies 147

Therapies Treatment Marketing Drugs 147

PPD

NOVEMBER 11, 2024

As a result, biopharma and biotech companies working to bring their drug pipelines to the market require deep expertise from trusted partners to help deliver critical therapies for their patients. However, getting essential treatments to patients quickly and safely requires more than just technological innovation. billion in 2023 to 1.2

Drug Development 97

Drug Development Clinical Trials Drugs Small Molecule 97

Drug Target Review

SEPTEMBER 7, 2023

The first clinical candidate, BSB-1001, aims to transform leukemia treatment by targeting minor histocompatibility antigen-1. Together, TCX-101 and TCX-102 allow BlueSphere to have a broader reach in the high-risk leukaemia treatment space where a high unmet medical need exists. -leukaemia effects and reducing graft-vs.-host

Treatment 98

Treatment Licensing Licensing Disease 98

Drug Patent Watch

DECEMBER 12, 2024

This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies. Understanding the Pharmaceutical Market Dynamics The pharmaceutical industry is a complex ecosystem where branded drugs and generics coexist, each playing a vital role in patient care and market dynamics.

Licensing 96

Licensing Licensing Drugs Clinical Trials 96

Conversations in Drug Development Trends

MAY 30, 2024

Since marketing authorization for the first breakthrough treatment in 1994, the steady increase in clinical trials reflects the community’s commitment to finding effective ALS treatments despite the numerous hurdles associated with clinical trial design, from proof-of-concept to pivotal trials. The MAA file in the E.U.

Treatment 81

Treatment Clinical Trials Small Molecule Therapies 81

Drug Patent Watch

JANUARY 21, 2025

The rising cost of brand-name medications has left millions of people struggling to afford the treatments they need to manage their conditions. This is a win-win for everyone involved patients get the treatments they need, and healthcare systems can allocate resources more efficiently. So, what's the future hold for biosimilars?

Biosimilars 95

Biosimilars Government Treatment Pharmaceuticals 95

Drug Patent Watch

DECEMBER 9, 2024

From Lab to Market: The Long Road of Drug Development Once a promising compound is identified, it enters the long and costly process of drug development. Taxol: From Pacific Yew to Cancer Treatment Taxol (paclitaxel), a widely used cancer drug, was originally isolated from the bark of the Pacific yew tree.

Drugs 97

Drugs Drug Development Pharmaceuticals Production 97

Cytel

MAY 7, 2024

Here we explore the evolution and impact of market exclusivity policies in the EU and US, highlighting their role in fostering innovation and accessibility in rare disease treatment. Market exclusivity for orphan drugs traces back to the early 1980s in the United States, with the landmark Orphan Drug Act of 1983.

Marketing 59

Marketing Production Drugs Disease 59

biobide

DECEMBER 1, 2023

Cannabis derivatives In 2022 the global legal cannabis market was valued at USD 22.1 This is forecasted to grow rapidly, with a growth rate of 25.5%

Treatment 97

Treatment Production Marketing Research 97

Fierce BioTech

NOVEMBER 9, 2023

New Treatments Hold Significant Promise, but are Marketing Teams Helping Life Sciences Companies Deliver on this Potential? New whitepaper from PurpleLab illustrates how real world data can help life sciences companies successfully market new drug innovations to patients. Download now.

Science 52

Science Marketing Treatment Drugs 52

Fierce BioTech

MARCH 6, 2025

AI-powered digital phenotyping and real-world data (RWD) offer new ways to locate overlooked patient populations, identify gaps between clinical guidelines and real-world treatment patterns, and optimize market positioning and messaging.

Treatment 75

Treatment Therapies Marketing 75

PPD

MARCH 11, 2025

Developing treatments for individuals living with rare diseases is critical, but orphan drug development is laden with unique obstacles that necessitate innovative, multifaceted approaches. This limited pool poses significant barriers to conducting statistically significant studies and validating the efficacy and safety of new treatments.

Drug Development 52

Drug Development Clinical Trials Disease Trials 52

Drug Target Review

APRIL 7, 2025

Susceptibility or risk biomarkers can detect the likelihood of a patient developing a disease or medical condition, which is crucial for treatments that are most effective before the onset of symptoms. A biomarker is a measurable indicator of a biological process, disease state, or response to a treatment.

Clinical Development 59

Clinical Development Clinical Trials Clinical Pharmacology Trials 59

Broad Institute

JULY 11, 2024

Targeted drug treatment leads tumor cells to imitate viral infection By Ari Navetta July 11, 2024 Breadcrumb Home Targeted drug treatment leads tumor cells to imitate viral infection Exploiting "viral mimicry," mIDH1 inhibitors trick tumors into thinking they are infected with a virus.

Treatment 72

Treatment Immune Response Drugs Virus 72

Antidote

SEPTEMBER 25, 2023

Clinical trials are how researchers advance their knowledge about potential new treatments, including medications, medical devices, and lifestyle interventions. Before any new treatment becomes available on the market, it must go through this process, as required by the FDA.

Clinical Trials 128

Clinical Trials Trials FDA Treatment 128

Drug Target Review

JULY 4, 2023

These therapies have broadened treatment options for patients to expand beyond the more traditional small molecule drug alternatives. ADCs have the potential to redress the poor balance between safety and efficacy seen with traditional cancer treatment options. 3D rendering of Antibody Drug Conjugate Molecules.

Small Molecule 145

Small Molecule Drugs Clinical Pharmacology Trials 145

National Institute on Drug Abuse: Nora's Blog

MARCH 6, 2025

Advancing reduction of drug use as an endpoint in addiction treatment trials astewart Thu, 03/06/2025 - 09:59 Nora's Blog March 18, 2025 Image Getty Images/ SolStock This blog was also published in the American Society of Addiction Medicine (ASAM) Weekly on March 18, 2025.&

Treatment 69

Treatment Trials Clinical Trials Drugs 69

Drug Target Review

FEBRUARY 21, 2024

This is a time when several promising treatments – including mRNA vaccines, BiTE therapies and CAR-T cell therapy, are essentially in competition with each other – they all have a common goal of treating the same disease, but they are approaching the objective from different angles.

Therapies 64

Therapies Treatment Vaccine FDA Approval 64

Drug Target Review

AUGUST 6, 2024

Autoimmune diseases : Rheumatoid Arthritis : ADCs targeting specific immune cells or inflammatory mediators can provide more precise treatment options with potentially fewer side effects. Obesity : By targeting adipose tissue or specific metabolic pathways, ADCs could offer new treatments for obesity and related metabolic disorders.

Therapies 119

Therapies Pharmaceutical Companies Disease Treatment 119

Perficient: Drug Development

NOVEMBER 14, 2023

Salesforce Marketing Cloud offers a powerful solution for medical device companies and healthcare providers to improve patient outcomes. Salesforce is a leading customer relationship management platform that has found a multitude of applications within the healthcare industry. See how we’ve done it or contact us today!

Marketing 59

Marketing Production Treatment Science 59

FDA Law Blog: Biosimilars

SEPTEMBER 26, 2024

In fact, it has a whole page dedicated to “CDRH Innovation,” which states that CDRH “is committed to advancing public health by helping to bring innovative technologies to market.” Manufacturers can expect increased interaction with the review team and prioritized review of the marketing submission.” So what can be done?

Marketing 64

Marketing Clinical Trials FDA Trials 64

Conversations in Drug Development Trends

OCTOBER 14, 2024

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. Innovations in Autoimmune Research: A New Era of Treatment In recent years, autoimmune and bone health research has entered a new era of innovation.

Research 52

Research Clinical Trials Therapies Immune Response 52

FDA Law Blog: Biosimilars

JUNE 12, 2024

Gibbs — It’s been over a year and a half since Over-the-Counter (“OTC”) hearing aids became legal, and it’s not clear that they’ve made the difference in hearing loss treatment that Congress anticipated. (FDA Koblitz & Jeffrey N. FDA once estimated that OTC hearing aids would save patients over $3000.)

FDA 111

FDA Regulations Treatment Licensing 111

DS in Pharmatics

JUNE 10, 2023

On April 12, 2023, BeNeLuxA1 announced that negotiations failed to secure reimbursement for Libmeldy, a gene therapy developed by Orchard Therapeutics for the treatment of metachromatic leukodystrophy, on grounds of price. In the UK, an initial application to NICE was rejected as well back in 2020. This is a huge […]

Marketing 66

Marketing Therapies Treatment 66

PPD

JUNE 27, 2024

The PPD clinical research business of Thermo Fisher Scientific has made significant contributions to these indications — our experts have conducted pivotal clinical studies for at least four molecules now on the market. Accelerate your alopecia areata treatments.

Treatment 52

Treatment Clinical Trials Clinical Research Small Molecule 52

Drug Target Review

DECEMBER 9, 2024

Baker’s model could revolutionise drug development, synthetic biology, and nanotechnology, opening possibilities for new medical treatments, vaccines, nanomaterials, and sensors. With these exclusive rights, they can establish a competitive edge, control market entry, and potentially set higher prices due to the lack of competition.

Engineering 105

Engineering International Drug Development Science 105

Drug Target Review

SEPTEMBER 5, 2024

This was very challenging for me and at that moment I decided to get experience from later stage products and therefore took on the role as Global Product Director for late-stage marketed cardiovascular products. In addition, we were a US and Swedish group working together with all that comes with that in form of cultural challenges.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111

The Premier Consulting Blog

NOVEMBER 6, 2024

Inhaled combination products (ICP) have emerged as a significant advancement in the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary conditions. What regulatory division governs ICPs? ICPs are subject to rigorous regulatory scrutiny due to their complexity.

Production 52

Production FDA Compliance Disease 52

Fierce BioTech

OCTOBER 9, 2023

Join us for a webinar on Tuesday, Novermber 14th, featuring Sara Mallatt Stahl, Director of Healthcare Research at AlphaSense.

Marketing 52

Marketing Science Treatment Disease 52

Fierce BioTech

MAY 22, 2024

So, how can pharmaceutical and biotech companies enter this market, and how can EAPs support and facilitate future successful commercialization? This webinar will delve into the benefits of Expanded Access Programs in Europe. Click here to login. Listing Image Sciensus_ListingLogo_250x190.png On Demand Start Date Tue, 06/25/2024 - 12:00

Marketing 52

Marketing Regulations Pharmaceuticals Treatment 52